Summary

Allergy Diagnostics Market Size
The global allergy diagnostics market size was valued at $6.64 billion in 2024 and is projected to reach $12.68 billion by 2030, growing at a CAGR of 11.4% during the forecast period.

Allergy Diagnostics Market Overview
Allergy diagnostics is the branch of medical science dedicated to identifying and analyzing allergic reactions in individuals. It encompasses a variety of tests and procedures aimed at pinpointing specific allergens that trigger allergic responses in patients. These diagnostic methods may include skin prick tests, blood tests, patch tests, and oral food challenges, among others. By accurately identifying the allergens causing adverse reactions, healthcare professionals can devise effective treatment plans and strategies for managing allergies in patients. Allergy diagnostics play a crucial role in healthcare, facilitating the diagnosis and management of allergic conditions to improve patients' quality of life.

Allergy Diagnostics Market Dynamics
• The allergy diagnostics market has a promising growth potential due to several factors which includes the increasing prevalence of allergic diseases worldwide, technological advancements in diagnostic techniques, and growing demand for personalized medicine and targeted therapy.
• Additionally, rising awareness about early diagnosis and treatment of allergies and expansion of healthcare infrastructure in emerging economies are the prominent factors driving the growth of the market.
• However, high costs of allergy diagnostic instruments and stringent regulatory requirements for approval of diagnostic products are restraining the market growth.
• On the contrary, integration of artificial intelligence in allergy diagnostics and the expansion of allergy testing services in retail pharmacies are creating opportunities for market growth.

By End User, Diagnostic Laboratories Segment held the Larger Market Share, and it would continue on this Path during the Forecast Period
The diagnostic laboratories segment dominated the market share and is expected to maintain its leading position throughout the forecast period owing to the availability of centralized facilities equipped with advanced equipment and trained personnel capable of conducting a wide range of allergy tests. Patients often rely on these laboratories to obtain accurate and reliable results for their allergy-related concerns. Additionally, diagnostic laboratories offer comprehensive allergy testing panels that cover a broad spectrum of allergens, allowing healthcare providers to identify specific triggers effectively. Moreover, the increasing prevalence of allergic diseases worldwide has led to a surge in demand for allergy testing services, driving patients to seek diagnosis and treatment in diagnostic laboratories. Furthermore, advancements in technology have enhanced the capabilities of diagnostic laboratories, enabling them to offer innovative allergy diagnostic tests with improved accuracy and efficiency. Overall, the diagnostic laboratories segment plays a crucial role in meeting the growing demand for allergy diagnostics by providing accessible, comprehensive, and reliable testing services to patients.

By Geography, North America Dominates by Being the Largest Market for Allergy Diagnostics
North America leads as the primary market for allergy diagnostics, holding the largest share in the industry during the forecast period due to rising prevalence of allergic rhinitis, coupled with increased awareness of proper diagnostic procedures across the region. In 2022, the U.S. asserted its dominance within the North America market and is anticipated to sustain healthy growth with highest CAGR throughout the analysis period. Factors contributing to this trend include a favorable return scenario, heightened funding for allergy diagnostic companies facilitating innovative product launches, and a surge in demand for rapid diagnostic test kits. Additionally, the U.S. witnesses a consistent increase in the population with food and skin-related allergies.
• According to the centers for disease control and prevention data in 2021, approximately one-third of adults aged 18 and over experienced eczema, seasonal, or food allergies, with a higher prevalence among non-Hispanic black adults and women in the 18-44 age group. Notably, allergies rank as the sixth leading cause of chronic illnesses in the country.

Key Target Audience:
• Healthcare Providers and Facilities
• Diagnostic Test Manufacturers
• Pharmaceutical Companies
• Allergy Specialists
• Healthcare Professionals

List of the Key Players Profiled in the Report Includes:
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Erba Group
• Lincoln Diagnostics Inc.
• Omega Diagnostics Group PLC
• Siemens Healthcare Diagnostics, Inc.
• Stallergenes SA
• Astra Biotech GmbH
• ACON Laboratories Inc.
• AESKU.GROUP GmbH
• HOB Biotech Group Corp. Ltd.
• HYCOR Biomedical

Recent Developments:
• In November 2023, Siemens Healthineers has partnered with the National Institute of Allergy and Infectious Diseases to enhance antibiotic treatment for patients with sepsis. Collaborating with Janus-I Science and the Louis Stokes Cleveland Veterans Affairs Medical Center (VAMC), the team aims to create an innovative diagnostic tool leveraging next-generation sequencing. This tool aims to swiftly detect and identify various bacteria and fungi, along with providing insights into their probable resistance to specific antibiotics, all within a six-hour window post-blood draw.
• In May 2023, Thermo Fisher Scientific has unveiled plans to extend access to ImmunoCAP™ Specific IgE tests to a broader patient base throughout the United States. The ImmunoCAP specific IgE regional respiratory profiles, now accessible at The Little Clinic® locations, streamline the process by requiring just one blood draw, which is then analyzed at an offsite clinical laboratory. By expanding into The Little Clinic sites, more patients will have the opportunity to take proactive steps towards managing their allergies, facilitating early intervention and prevention strategies.

Market Segmentation:
The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Market by, Product & Service:
• Instruments
• Consumables
• Services

Market by, Test Type:
• In Vivo
• In Vitro

Market by, Allergen:
• Drug Allergens
• Inhaled Allergens
• Food Allergens
• Other Allergens

Market by, End User:
• Hospital-based Laboratories
• Diagnostic Laboratories
• Other End Users

Market by, Geography:
The allergy diagnostics market report also analyzes the major geographic regions and countries of the market. The regions and countries covered in the study include:
• North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis
• Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis
• South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis
• Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis

Scope of the Report:
The report “Global Allergy Diagnostics Market: Industry Analysis, Opportunities and Forecast up to 2030” by Diligence Insights provides a detailed analysis of the present market and future outlook with market estimates and forecasts for all specified segments, encompassing both global and regional perspectives as outlined within the research framework. The study includes historical market data for the years 2022, 2023 and offers revenue estimations for 2024, and project forecasts spanning from 2025 to 2030. It places significant emphasis on the examination of market trends, key industry participants, supply chain developments, technological advancements, pivotal milestones, and prospective strategies. Comprehensive market assessments are carried out across major geographic regions, including North America, Europe, Asia Pacific, South America, and Middle East & Africa. As such, this report constitutes a valuable resource for current industry stakeholders, newcomers to the field, and potential investors.

The study offers an in-depth market analysis, drawing insights from industry experts across the value chain. A special focus has been made on 25 countries, including the United States, Canada, Mexico, the United Kingdom, Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, and South Africa, among others. The market data has been meticulously collected through extensive primary interviews and comprehensive secondary research. Market size determination is rooted in the revenue generated from sales across all the specified segments and sub-segments as defined within the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The report offers insights into the following aspects:
• Analysis of major market trends, factors driving, restraining, threatening, and providing opportunities for the market.
• Analysis of the market structure by identifying various segments and sub-segments of the market.
• Understand the revenue forecast of the market for North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
• Analysis of opportunities by identification of high-growth segments/revenue pockets in the market.
• Understand major player profiles in the market and analyze their business strategies.
• Understand competitive developments such as joint ventures, alliances, mergers and acquisitions, and new product launches in the market.

ページTOPに戻る

Table of Contents

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations

2 Executive Summary

3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions

4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges

5 Porter's Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market

6 Global Allergy Diagnostics Market by, Product & Service
6.1 Overview
6.2 Instruments
6.2.1 Luminometers
6.2.2 Immunoassay Analyzers
6.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers
6.3 Consumables
6.4 Services

7 Global Allergy Diagnostics Market by, Test Type
7.1 Overview
7.2 In Vivo
7.2.1 Intradermal Skin Test
7.2.2 Skin Prick Tests
7.2.3 Other In Vivo Test Types
7.3 In Vitro

8 Global Allergy Diagnostics Market by, Allergen
8.1 Overview
8.2 Drug Allergens
8.3 Inhaled Allergens
8.4 Food Allergens
8.5 Other Allergens

9 Global Allergy Diagnostics Market by, End User
9.1 Overview
9.2 Hospital-based Laboratories
9.3 Diagnostic Laboratories
9.4 Other End Users

10 Global Allergy Diagnostics Market by, Geography
10.1 Overview
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 New Zealand
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 UAE
10.6.2 Saudi Arabia
10.6.3 Qatar
10.6.4 Iran
10.6.5 South Africa
10.6.6 Rest of Middle East & Africa

11 Key Developments

12 Company Profiling
12.1 Thermo Fisher Scientific Inc.
12.1.1 Business Overview
12.1.2 Product/Service Offering
12.1.3 Financial Overview
12.1.4 SWOT Analysis
12.1.5 Key Activities
12.2 Danaher Corporation
12.3 Erba Group
12.4 Lincoln Diagnostics Inc.
12.5 Omega Diagnostics Group PLC
12.6 Siemens Healthcare Diagnostics, Inc.
12.7 Stallergenes SA
12.8 Astra Biotech GmbH
12.9 ACON Laboratories Inc.
12.10 AESKU.GROUP GmbH
12.11 HOB Biotech Group Corp. Ltd.
12.12 HYCOR Biomedical